PATHRYVA Trademark

Trademark Overview

On Thursday, December 30, 2021, a trademark application was filed for PATHRYVA with the United States Patent and Trademark Office. The USPTO has given the PATHRYVA trademark a serial number of 97197222. The federal status of this trademark filing is REGISTERED as of Tuesday, January 23, 2024. This trademark is owned by Ascendis Pharma Endocrinology Division A/S. The PATHRYVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting hypoparathyroidism, endocrine disorders and bone disorders
pathryva

General Information

Serial Number97197222
Word MarkPATHRYVA
Filing DateThursday, December 30, 2021
Status700 - REGISTERED
Status DateTuesday, January 23, 2024
Registration Number7282981
Registration DateTuesday, January 23, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting hypoparathyroidism, endocrine disorders and bone disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 5, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAscendis Pharma Endocrinology Division A/S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressHellerup DK-2900
DK
Party NameAscendis Pharma Endocrinology Division A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressHellerup DK-2900
DK
Party NameAscendis Pharma Endocrinology Division A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHellerup DK-2900
DK

Trademark Events

Event DateEvent Description
Tuesday, January 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 23, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, November 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 7, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 22, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, June 22, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, March 22, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 22, 2023NON-FINAL ACTION E-MAILED
Wednesday, March 22, 2023NON-FINAL ACTION WRITTEN
Wednesday, March 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 6, 2023ASSIGNED TO LIE
Thursday, December 22, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, December 19, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 19, 2022LETTER OF SUSPENSION E-MAILED
Monday, December 19, 2022SUSPENSION LETTER WRITTEN
Wednesday, December 7, 2022ASSIGNED TO EXAMINER
Wednesday, November 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 29, 2022ASSIGNED TO EXAMINER
Thursday, June 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 2, 2022NON-FINAL ACTION E-MAILED
Thursday, June 2, 2022NON-FINAL ACTION WRITTEN
Monday, May 23, 2022ASSIGNED TO EXAMINER
Wednesday, January 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 3, 2022NEW APPLICATION ENTERED

Related Keywords

pathryva preparations disorders treatment pharmaceutical bone diagnostic endocrine hypoparathyroidism detecting identifying